Safety of Modified Dust Mite Subcutaneous Immunotherapy in Severe Allergic Asthma

被引：0
|
作者：
Gonzalez, Ruperto [1 ]
Poza, Paloma [2 ]
Matheu, Victor [3 ]
Sanchez-Machin, Inmaculada [4 ]
机构：
[1] Hosp Ofra Torax, Santa Cruz de Tenerife, Spain
[2] Hosp Ofra Torax, Santa Cruz De Tenerife, Spain
[3] Hosp Ofra, Tenerife, Spain
[4] Hosp Ofra Torax, Tenerife, Spain
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2012.12.1400
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB205 / AB205
页数：1
相关论文
共 50 条
  • [41] Analysis of systemic reactions treated by epinephrine induced by subcutaneous immunotherapy to dust mite - a retrospective study on 14 cases with allergic rhinitis and asthma
    Li, M.
    Wang, X.
    Lin, J.
    Zhang, H.
    Li, Y.
    Jin, K.
    Li, C.
    ALLERGY, 2012, 67 : 417 - 417
  • [42] SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms
    Mosbech, Holger
    Canonica, G. Walter
    Backer, Vibeke
    de Blay, Frederic
    Klimek, Ludger
    Broge, Louise
    Ljorring, Christian
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (02) : 134 - U183
  • [43] Clinical Efficacy Of Subcutaneous and Sublingual Immunotherapy In Asthma and Rhinitis Children Sensitized To House Dust Mite
    Kim, Min-Ju
    Lee, Eun
    Park, Keun-Mi
    Hwang, Keum-Hee
    Jung, Young-Ho
    Yang, Song-Yi
    Lee, Jae-Eun
    Kim, Hee-Kyeong
    Lee, Hye-yeong
    Yu, Jin-ho
    Hong, Soo-Jong
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB146 - AB146
  • [44] Efficacy and safety of subcutaneous immunotherapy with pollen allergen extracts in asthma and allergic rhinoconjunctivitis
    Laurrabaquio Miranda, A.
    Celio Murillo, R.
    Rodiguez Santos, O.
    Tinoco Moran, I. O.
    Abou Kahir, F.
    Cuevas Castillejos, H. U.
    Cruz Suarez, M. A.
    Cruz Marmolejo, M. A.
    ALLERGY, 2013, 68 : 547 - 547
  • [45] Steroid-sparing effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics
    Blumberga, G.
    Groes, L.
    Haugaard, L.
    Dahl, R.
    ALLERGY, 2006, 61 (07) : 843 - 848
  • [46] Dropouts From Sublingual Immunotherapy and the Transition to Subcutaneous Immunotherapy in House Dust Mite-Sensitized Allergic Rhinitis Patients
    Chen, Huan
    Gong, Guo-qing
    Ding, Mei
    Dong, Xiang
    Sun, Yuan-li
    Wan, Lang
    Gao, Ya-dong
    FRONTIERS IN ALLERGY, 2022, 2
  • [47] Safety Of Sublingual Tablets Of House Dust Mite Allergen Extracts In Adults With House Dust Mite-Associated Allergic Asthma
    Zeldin, R. K.
    Betting, P.
    Le Gall, M.
    Rodriguez, P.
    Racaud, A.
    Demoly, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [48] Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma
    Eifan, Aarif O.
    Calderon, Moises A.
    Durham, Stephen R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (11) : 1543 - 1556
  • [49] Cost-effectiveness analysis of house dust mite allergen immunotherapy in children with allergic asthma
    Farraia, Mariana
    Paciencia, Ines
    Mendes, Francisca Castro
    Rufo, Joao Cavaleiro
    Shamji, Mohamed H.
    Agache, Ioana
    Moreira, Andre
    ALLERGY, 2022, 77 (09) : 2688 - 2698
  • [50] SQ HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IS WELL TOLERATED IN SUBJECTS WITH ALLERGIC ASTHMA
    Maloney, J.
    Hulstrom, V.
    Smith, I. Mosbech
    Nolte, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S59 - S59
12345